Get the Stockscreener App
21.09
4.09%
-0.90
After Hours:
21.00
-0.09
-0.43%
Elanco Animal Health Inc stock is traded at $21.09, with a volume of 5.27M.
It is down -4.09% in the last 24 hours and up +4.30% over the past month.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
See More
Previous Close:
$21.99
Open:
$21.69
24h Volume:
5.27M
Relative Volume:
0.75
Market Cap:
$10.48B
Revenue:
$4.45B
Net Income/Loss:
$205.00M
P/E Ratio:
52.72
EPS:
0.4
Net Cash Flow:
$372.00M
1W Performance:
-1.86%
1M Performance:
+4.30%
6M Performance:
+63.74%
1Y Performance:
+50.21%
1-Day Range:
$21.07
$21.89
1-Week Range:
$21.07
$23.09
52-Week Range:
$8.02
$23.09
Elanco Animal Health Inc Stock (ELAN) Company Profile
Name
Elanco Animal Health Inc
Sector
Phone
877-352-6261
Address
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
21.09 | 10.93B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
120.82 | 53.39B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.29 | 44.99B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.59 | 44.08B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
25.41 | 29.30B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
466.40 | 19.91B | 3.08B | 1.24B | 1.07B | 25.61 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-07-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Jul-17-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jun-26-25 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-09-24 | Initiated | UBS | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Market Perform |
| Sep-19-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-24 | Upgrade | Stifel | Hold → Buy |
| Dec-19-23 | Initiated | Jefferies | Buy |
| Dec-15-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Apr-20-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-18-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-16-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Sell |
| Jul-12-22 | Initiated | Piper Sandler | Neutral |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Oct-28-21 | Downgrade | Stifel | Buy → Hold |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jun-15-21 | Upgrade | Cleveland Research | Underperform → Neutral |
| May-11-21 | Upgrade | Barclays | Underweight → Equal Weight |
| May-11-21 | Upgrade | Gabelli & Co | Hold → Buy |
| Apr-15-21 | Initiated | Stifel | Buy |
| Mar-22-21 | Downgrade | Gabelli & Co | Buy → Hold |
| Feb-26-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-09-20 | Downgrade | Argus | Buy → Hold |
| Nov-09-20 | Downgrade | Barclays | Overweight → Underweight |
| Aug-20-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-13-20 | Resumed | Credit Suisse | Neutral |
| Aug-04-20 | Resumed | Goldman | Buy |
| Jul-27-20 | Downgrade | Cleveland Research | Neutral → Underperform |
| Apr-02-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Dec-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Nov-07-19 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-23-19 | Initiated | Barclays | Overweight |
| Aug-26-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-15-19 | Upgrade | UBS | Sell → Neutral |
| May-23-19 | Initiated | Guggenheim | Neutral |
| Mar-18-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-13-19 | Resumed | Morgan Stanley | Equal-Weight |
| Feb-12-19 | Initiated | William Blair | Mkt Perform |
| Jan-23-19 | Initiated | UBS | Sell |
| Jan-15-19 | Initiated | Argus | Buy |
| Oct-15-18 | Initiated | Morgan Stanley | Equal-Weight |
View All
Elanco Animal Health Inc Stock (ELAN) Latest News
Will Elanco Animal Health Incorporated (5EA) stock outperform benchmarksJuly 2025 Market Mood & Risk Controlled Daily Trade Plans - newser.com
Will Elanco Animal Health Incorporated stock beat international competitionQuarterly Earnings Summary & Community Supported Trade Ideas - newser.com
Can Elanco Animal Health Incorporated (5EA) stock double in coming yearsPortfolio Risk Report & Intraday High Probability Alerts - newser.com
Will Elanco Animal Health Incorporated (5EA) stock benefit from mergersQuarterly Portfolio Review & Verified Momentum Watchlists - newser.com
Will Elanco Animal Health Incorporated stock deliver shareholder valueJuly 2025 Momentum & Low Drawdown Momentum Trade Ideas - newser.com
Will Elanco Animal Health Incorporated (5EA) stock hit Wall Street targets2025 Investor Takeaways & Reliable Volume Spike Alerts - newser.com
Is Elanco Animal Health Incorporated stock a buy during volatile markets2025 Valuation Update & Fast Moving Stock Trade Plans - newser.com
Best data tools to analyze Elanco Animal Health Incorporated stockJuly 2025 Pullbacks & Proven Capital Preservation Tips - newser.com
Why institutional investors increase stakes in Elanco Animal Health Incorporated stock2025 Momentum Check & Real-Time Market Trend Scan - newser.com
Is Elanco Animal Health Incorporated meeting your algorithmic filter criteriaCEO Change & Weekly Momentum Picks - newser.com
Will Elanco Animal Health Incorporated stock recover faster than marketWeekly Trade Analysis & Reliable Intraday Trade Alerts - newser.com
Will Elanco Animal Health Incorporated (5EA) stock boost dividends furtherJuly 2025 Snapshot & Consistent Income Trade Recommendations - newser.com
Elanco Animal Health Incorporated stock prediction for this week2025 Dividend Review & Weekly Setup with ROI Potential - newser.com
What to expect from Elanco Animal Health Incorporated in the next 30 days2025 Price Targets & Weekly High Return Opportunities - newser.com
Pet Healthcare Spending Is Soaring. These Stocks Are Positioned to Clean Up - AOL.com
Is Elanco Animal Health Incorporated (5EA) stock positioned for digital growth era2025 Price Action Summary & Low Drawdown Momentum Ideas - Fundação Cultural do Pará
Pet Healthcare Spending Is Soaring. These 5 Stocks Are Positioned to Clean Up - 24/7 Wall St.
Alloy Partners Launches OneHealth Studio to Create Startups at the Convergence of Animal, Plant and Human Health - Investing News Network
Elanco Animal Health Incorporated’s volatility index tracking explainedShort Setup & Weekly High Conviction Trade Ideas - newser.com
Elanco (NYSE: ELAN) teams with Alloy to launch OneHealth Studio for One Health innovation - Stock Titan
Elanco Animal Health Inc Stock (ELAN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.50%
1.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):